Matthew R. Kane, President and CEO at PRECISION BIOSCIENCES INC (DTIL), sold 19,482 shares at $8.67 ($169K) on 2021-04-12, disclosed to the SEC on 2021-04-14.
Open-market sale of $169k DTIL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.67 | 9,741 | $84K | 50.0% |
| 2 | $8.67 | 9,741 | $84K | 50.0% |
| Total | $8.67 avg | 19,482 | $169K | 100% |
| Filing → |
| DTIL | SELL | 2021-04-12 | $260K | — | Filing → |
| DTIL | SELL | 2021-03-16 | $221K | — | Filing → |
| DTIL | SELL | 2021-03-12 | $450K | — | Filing → |